Effects of DPP-4 Inhibitors on Cardiovascular System in Type 2 Diabetes

被引：0
|
作者：
Ohno, Yasuhiro [1 ]
Tanaka, Yoichi [1 ]
Fujimoto, Mika [1 ]
Maruyama, Yasunori [1 ]
机构：
[1] Kinki Univ, Sakai Hosp, Fac Med, Sakai, Osaka, Japan
来源：
ENDOCRINE REVIEWS | 2014年 / 35卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
MON-1052
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Healthcare Costs Among Adults with Type 2 Diabetes Initiating DPP-4 Inhibitors
    Amanda M. Farr
    John J. Sheehan
    Matthew Brouillette
    David M. Smith
    Stephen S. Johnston
    Iftekhar Kalsekar
    Advances in Therapy, 2016, 33 : 68 - 81
  • [32] Ten years of experience with DPP-4 inhibitors for the treatment of type 2 diabetes mellitus
    Giorgio Sesti
    Angelo Avogaro
    Sara Belcastro
    Benedetta Maria Bonora
    Marina Croci
    Giuseppe Daniele
    Marco Dauriz
    Francesco Dotta
    Caterina Formichi
    Simona Frontoni
    Cecilia Invitti
    Emanuela Orsi
    Fabiana Picconi
    Veronica Resi
    Enzo Bonora
    Francesco Purrello
    Acta Diabetologica, 2019, 56 : 605 - 617
  • [33] Renoprotective Effects of DPP-4 Inhibitors
    Kawanami, Daiji
    Takashi, Yuichi
    Takahashi, Hiroyuki
    Motonaga, Ryoko
    Tanabe, Makito
    ANTIOXIDANTS, 2021, 10 (02) : 1 - 17
  • [34] IMPROVED CARDIOVASCULAR OUTCOMES WITH DPP-4 INHIBITORS IN DIABETES - A META-ANALYSIS
    Home, Philip
    ATHEROSCLEROSIS, 2012, 223 (02) : 533 - 533
  • [35] THE ROLE OF DPP-4 INHIBITORS IN ANGIOGENESIS IN DIABETES
    Chan, Jenq-Shyong
    Wu, Tao-Cheng
    Chen, Jaw-Wen
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 171 - 172
  • [36] DPP-4 inhibitors, heart failure and type 2 diabetes: all eyes on safety
    Paneni, Francesco
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2015, 5 (06) : 471 - 478
  • [37] DPP-4 inhibitors for the treatment of type 2 diabetes: a methodology overview of systematic reviews
    Juan Ling
    Long Ge
    Ding-hua Zhang
    Yong-feng Wang
    Zhuo-lin Xie
    Jin-hui Tian
    Xiao-hui Xiao
    Ke-hu Yang
    Acta Diabetologica, 2019, 56 : 7 - 27
  • [38] Healthcare Costs Among Adults with Type 2 Diabetes Initiating DPP-4 Inhibitors
    Farr, Amanda M.
    Sheehan, John J.
    Brouillette, Matthew
    Smith, David M.
    Johnston, Stephen S.
    Kalsekar, Iftekhar
    ADVANCES IN THERAPY, 2016, 33 (01) : 68 - 81
  • [39] DPP-4 inhibitors for the treatment of type 2 diabetes: a methodology overview of systematic reviews
    Ling, Juan
    Ge, Long
    Zhang, Ding-hua
    Wang, Yong-feng
    Xie, Zhuo-lin
    Tian, Jin-hui
    Xiao, Xiao-hui
    Yang, Ke-hu
    ACTA DIABETOLOGICA, 2019, 56 (01) : 7 - 27
  • [40] Efficacious and safe management of type 2 diabetes mellitus using DPP-4 inhibitors
    S., Ametov A.
    Karpova, E., V
    DIABETES MELLITUS, 2010, 13 (02): : 69 - 75
12345